Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
(NASDAQ: NRIX) Delayed: 18.86 +0.21 (1.13%)
Previous Close $18.65    52 Week High $ 
Open $18.49    52 Week Low $ 
Day High $19.12    P/E N/A 
Day Low $18.39    EPS $ 
Volume 1,947,200